Advertisement
Journal Home
Search for

Volume 10, Issue 2, Pages 87-93 (April 2008)


View previous. 14 of 14

Double Balloon Endoscopy in Celiac Disease

S.J.B. Van Weyenberg, MDCorresponding Author Informationemail address, S.V.A. Jarbandhan, MD, C.J.J. Mulder, MD, PhD, M.A.J.M. Jacobs, MD, PhD

In patients with celiac disease (CD), double balloon endoscopy (DBE) allows evaluation of endoscopic signs of celiac disease in the small bowel distal to the duodenum and enables obtaining biopsy specimens. DBE in CD is indicated especially in patients: (1) who are over 50 years old at age of diagnosis and fail to respond on a gluten-free diet (GFD) and findings of gastroduodenoscopy offer no explanation; (2) who previously responded on a GFD but are experiencing weight loss, abdominal pain, diarrhea, or anemia and findings of gastroduodenoscopy offer no explanation; (3) with a history or clinical findings suggestive of small bowel stenosis; (4) in whom radiological findings are suggestive of small bowel malignancy; and (5) in whom video capsule endoscopy revealed lesions suggestive of ulcerative jejunitis, enteropathy associated T-cell lymphoma, or small bowel adenocarcinoma. DBE allows endoscopical visualization of CD-related morphological abnormalities of the small bowel mucosa, obtaining biopsy specimens, and the marking of lesions for surgical resection.

Article Outline

Abstract

When to Perform DBE in CD

Technical Aspects: Which Endoscope to Use

Outcomes

Endoscopic findings with DBE

Uncomplicated CD

RCD

Ulcerative Jejunitis and EATL

Small Bowel Adenocarcinoma

Biopsy

Tattooing

Additional Imaging

VCE

Computed Tomography Enteroclysis

Magnetic Resonance Enteroclysis

Conventional Enteroclysis

Conclusions

References

Copyright

Celiac disease (CD) is a T-cell-mediated autoimmune disorder induced by dietary gluten. Its prevalence is estimated to be around 1 in 100 to 250 people.1, 2, 3 Diagnostic criteria have been defined in 2001.4 In summary, CD does not require further confirmation if the diagnosis is based on duodenal histology showing villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis while using a gluten-containing diet, which normalizes on a gluten-free diet (GFD). The presence of circulating antibodies against endomysium (EMA) or tissue transglutaminase (tTGA) supports the diagnosis but is not a requirement. With a GFD, most patients experience improvement of clinical symptoms and quality of life.

A small proportion (2-10%) of CD patients fails to improve after the introduction of a GFD.5 When the diagnosis of CD has been reassessed and confirmed and no dietary mistakes seem to occur, the diagnosis refractory celiac disease (RCD) has to be considered.6 RCD is defined as persisting histological abnormalities in a patient with a strict GFD. Two types of RCD can be distinguished. Immunohistological, RCD I is characterized by normal expression of T-cell antigens, whereas in RCD II, the intraepithelial T-cell populations are aberrant and monoclonal in the majority of cases. The differences between RCD I and RCD II are also expressed in survival. Al-Toma and coworkers showed that the overall 5-year survival in RCD I is 96%, and in RCD II 58%.7 Within a mean follow-up of 5 years, no patients with RCD I progressed to RCD II or enteropathy-associated T-cell lymphoma (EATL), whereas 52% percent of the RCD II patients developed EATL within 4 to 6 years after the diagnosis of RCD II. EATLs are derived from intraepithelial lymphocytes and usually have a high grade of malignancy.8 Therapeutic options for RCD I include immunosuppressive therapy, whereas in RCD II, chemotherapy and stem cell transplantation are considered options.9, 10, 11 Therapeutic options for EATL are disappointing.12

Patients with CD have a 40- to 80-fold increased risk of developing adenocarcinoma of the small bowel.11 The occurrence of small intestinal obstruction, weight loss, or anemia should raise suspicion of small bowel adenocarcinoma in a patient with CD. On the other hand, small bowel carcinoma can be the presenting sign of non-previous diagnosed CD.

Up to the development of double balloon endoscopy (DBE) by Yamamoto, endoscopic examination of the small bowel in patients with CD, including direct visualization and the possibility of obtaining biopsy specimens for histological assessment, was confined to the duodenum using conventional upper gastrointestinal endoscopy or to the distal jejunum using push enteroscopy. The distal ileum could be reached with ileocolonoscopy. Until the introduction of video capsule endoscopy (VCE), the remaining small bowel could only be assessed using intraoperative enteroscopy.

Up to the late 1980s, it was routine to obtain small bowel specimens with a Crosby capsule. Since modern video endoscopes have been developed, it has been demonstrated that duodenal biopsies are sufficient to diagnose CD, since distal duodenal and jejunal histological findings are closely correlated.13, 14 Although VCE has proven to be a breakthrough in the diagnosis of small bowel diseases, the inability to obtain biopsy specimens limits its use in the management of complicated CD. Therefore, when mucosal tissue is required for diagnosis or a therapeutic intervention such as stricture dilation or hemostasis is planned, DBE has become the standard endoscopic method for the evaluation of small bowel disorders.15, 16

When to Perform DBE in CD 

return to Article Outline

In a patient diagnosed with CD who shows clinical response on a GFD, duodenal biopsy specimens are sufficient to monitor mucosal recovery.17 Since RCD and small bowel malignancies are extremely rare in asymptomatic CD patients, screening for these complications in the absence of symptoms is not indicated.18

DBE should be considered in patients with CD: (1) who are over 50 years old at age of diagnosis and fail to response on a GFD and findings of EGD offer no explanation; (2) who previously responded on a GFD but are experiencing weight loss, abdominal pain, diarrhea, or anemia and findings of EGD offer no explanation; (3) with a history or clinical findings suggestive of small bowel stenosis; (4) in whom radiological findings are suggestive of small bowel malignancy; and (5) in whom VCE revealed lesions suggestive of ulcerative jejunitis, EATL, or small bowel adenocarcinoma.

One should be aware that, especially in older patients, RCD, EATL, or small bowel adenocarcinoma can be the presenting entities of CD. Therefore, in those situations a high index of suspicion for CD is warranted and DBE should be considered to visualize the small bowel and obtain histological samples.

Since CD-related abnormalities are almost exclusively located in the duodenum and jejunum, the preferred route of insertion should be antegrade.

Technical Aspects: Which Endoscope to Use 

return to Article Outline

Since, besides occasionally tattooing of lesions, no interventions are usually performed during DBE in patients with (complicated) CD, both the diagnostic (Fujinon EN450P5) and therapeutic (Fujinon EN450T5) DBE systems can be used. Although no research has been performed on the effect of DBE-endoscope diameter on the ease of obtaining biopsy specimens and the quality of biopsy specimens, we have the impression that the thicker EN450T5 endoscope allows easier introduction and withdrawal of the biopsy forceps, which could be a factor in the decision which endoscope to use, especially when many biopsy specimens are needed for flow cytometric analysis.

Outcomes 

return to Article Outline

Endoscopic findings with DBE 

Uncomplicated CD 

Several endoscopic signs have been described in CD. Most of the data concerning endoscopical signs date from the pre-DBE era and are limited to duodenum and proximal jejunum findings. Many of these signs can be encountered in the duodenum and are within the reach of a standard gastroscope. Sensitivity of these signs is around 50%, whereas specificity is nearly 100%.19

Flattened villi are the endoscopical depiction of villous atrophy. With the tip of the endoscope close to the mucosa, villi appear short and broadened (Fig. 1). A better view can be appreciated after rapid instillation of water, which allows the villous tips to float.20 If total villous atrophy is present, the mucosa can have a mosaic, or cobblestone-like appearance (Fig. 2). Scalloping of folds can be encountered throughout the small bowel (Fig. 3). The normally smooth bordered folds appear notched.21 This sign is best visualized in a maximally insufflated part of the small bowel. The scalloping appearance is probably the result of mucosal grooves, which can also be encountered between mucosal folds. Visualization of submucosal blood vessels has also been reported as a sign of mucosal atrophy in CD. We do not consider this a specific sign (Fig. 4).22


View full-size image.

Figure 1. Total and partial villous atrophy in the jejunum of a 70-year-old male with longstanding CD. Histopathological examination revealed Marsh IIIB, without evidence for RCD II or EATL.



View full-size image.

Figure 2. Cobblestone-like appearance of the jejunal mucosa in the same patient as in Figure 1. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 3. Scalloping of jejunal folds. Same patient as in Figure 1, Figure 2. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 4. Visualization of submucosal blood vessels in the jejunum of a 34-year-old male with iron deficiency anemia without a known cause. Pathological examination revealed no abnormalities. (Color version of figure is available at www.techgiendoscopy.com.)


A reduction or loss of folds in the jejunum is a typical sign in radiology of the small bowel, especially when combined with an increased number of ileal folds.23, 24, 25, 26, 27, 28, 29 In endoscopy, the reduction or loss of jejunal folds is defined as less than four folds in an endoscopic view of maximally insufflated jejunum.26 There are no data on increased ileal folds as an endoscopic sign of celiac disease. The decreased number of folds, combined with the disappearance of villi and mucosal atrophy can give the jejunal mucosa the aspect of colonic mucosa.

Dickey and coworkers described duodenal erosions in five patients with CD.27 In at least one patient, the erosions did not disappear after GFD, which could suggest RCD (Fig. 5). In our opinion, the presence of erosions should raise the suspicion of ulcerative jejunitis.29


View full-size image.

Figure 5. Solitary erosion in the proximal jejunum of a 64-year-old male patient, 2 years after the diagnosis of CD had been established. Pathology showed Marsh IIIB. T-cell flowcytometry showed 65% aberrant T-cells, consistent with RCD II. A more distal lesion proved to be EATL. (Color version of figure is available at www.techgiendoscopy.com.)


Once familiar with the variances in appearance of the above-mentioned signs, they can be appreciated in the small bowel of a great part of CD patients. Lack of these signs in the proximal small bowel of a CD patient in whom DBE has been indicated should, however, never give the false impression that no gross abnormalities can be encountered more distal.

RCD 

Endoscopy alone cannot distinguish between uncomplicated CD and RCD. Obtaining biopsy specimens is therefore of major importance in suspected RCD, not only to confirm RCD and exclude other forms of enteropathy, but also, if the diagnosis CD stands, to determine the type of RCD.

In a recent study, Hadithi and coworkers found loss of jejunal folds and scalloping of jejunal folds in all 14 patients with RCD.28 Nodularity was present in 9 patients (64%) and visible submucosal vessels in 2 patients (14%). Jejunal erosions were encountered in 1 patient (7%). These signs could not discriminate between RCD I and RCD II. In 6 patients, small bowel histology improved in the middle or distal part of the small bowel. In 7 patients, flow-cytometry showed an increased population of aberrant T-cells, suggestive of RCD II. No ulceration (predefined as mucosal defects of at least 5 mm in diameter) or stenosis was found in this group.28 Recently, DBE-assisted chromoendoscopy using indigo carmin was used to characterize the mucosal lesions in a patient with RCD.30

Ulcerative Jejunitis and EATL 

Although histological features of ulcerative jejunitis are often nonspecific, there is immunopathological and molecular evidence that most of such cases represent early T-cell lymphomas.11 Ulcerations of various sizes can be encountered isolated, clustered, or diffusely throughout the jejunum. They can appear as small, white, usually only slightly depressed, circular, or confluent lesions, or as larger, deeper ulcers (Figure 6, Figure 7). In our opinion, these findings indicate additional imaging of the part of the small bowel that has not been reached during antegrade DBE.


View full-size image.

Figure 6. Deep ulceration in the presence of villous atrophy in the jejunum of a 55-year-old female with longstanding CD. Histopathology of this lesion showed Marsh IIIC, with over 90% aberrant T-cells.



View full-size image.

Figure 7. Multiple ulcerations in the jejunum with edematous folds. Same patient as in Figure 6. Biopsy specimens from this site were consistent with RCD II, without the presence of lymphoma. (Color version of figure is available at www.techgiendoscopy.com.)


In our experience, isolated or multiple stenoses most often are encountered in patients with EATL. Biopsy specimens are, however, frequently nonspecific. Stenoses could reflect severe, circumferential ulceration. Stenoses can be short, resembling webs, or up to 1 or 2 centimeters long (Figure 8, Figure 9). Although no reports of perforation of stenosis during DBE have been published, we usually try to avoid balloon insufflation near such strictures. However, dilation by the balloon of either the endoscope or the overtube may occur unintentionally (Fig. 10). Only once has balloon dilation of a CD-related stricture been performed in our center, to pass the stricture with the endoscope and obtain biopsy specimens of a distally located suspicious mass, suspected to be an EATL-localization. Severe stenosis often is associated with food impaction and prestenotic dilation (Fig. 11).


View full-size image.

Figure 8. Stenosis in the presence of total villous atrophy in a 66-year-old male patient in whom CD was diagnosed 1 year before. Pathological examination showed a monoclonal T-cell population, consistent with EATL. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 9. Short, web-like stenosis with ulceration in the jejunum of the same patients as in Figure 6. Histopathology showed no localization of EATL at this site. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 10. Unintentional dilation of a web-like stricture due to the balloons of the endoscope or overtube in a 65-year-old female with a 40-year history of celiac disease. Pathological examination showed Marsh IIIA, without aberrant T-cells, consistent with RCD I. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 11. Ulcerative pinpoint stenosis with food impaction in the jejunum of the same patient as in Figure 6. Histological examination showed the localization of EATL. (Color version of figure is available at www.techgiendoscopy.com.)


Endoscopically, EATLs can present as small circular or confluent ulcers, or as large ulcerative protruding masses, with an irregular and vulnerable surface, often with necrosis or stenosis (Figure 12, Figure 13, Figure 14). Villi are usually absent. In the study by Hadithi and coworkers, five patients were diagnosed with EATL and two with ulcerative jejunitis.28 Ulceration was found in all patients with EATL, whereas in only one patient stenosis was encountered. In two patients with ulcerative lesions, no EATL could be found, despite the many biopsy specimens that had been taken. None of the findings in patients with EATL or ulcerative jejunitis could have been found with conventional EGD.


View full-size image.

Figure 12. Irregular, ulcerative mass preceding a stenosis of the distal jejunum. Same patient as in Figure 6. Histological examination showed the localization of EATL. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 13. Isolated oval lesion, with slightly elevated irregular borders and a central, ulcerative indentation in the jejunum of the same patient as in Fig. 9. Pathological examination showed this lesion to be EATL. (Color version of figure is available at www.techgiendoscopy.com.)



View full-size image.

Figure 14. Irregular circular ulcerative lesions, with loss of folds and prestenotic dilation the jejunum of the same patient as in Figure 7. Pathological examination showed these lesions to be EATL. (Color version of figure is available at www.techgiendoscopy.com.)


Small Bowel Adenocarcinoma 

Small bowel adenocarcinoma of the small bowel is histologically identical to colorectal adenocarcinoma. Endoscopically, they often appear as irregular, ulcerative lesions, often leading to stenosis and prestenotic dilation (Fig. 15). It is not certain whether the adenoma–carcinoma sequence observed in colorectal cancer also occurs in the small bowel. The growth pattern of adenocarcinoma of the small bowel usually tends to be more exophytic than in lymphoma. However, no certain distinction can be made without extensive sampling for histopathological examination.


View full-size image.

Figure 15. Primary adenocarcinoma of the jejunum. Note the irregular, tumorous, ulcerative lesion which can often leading to stenosis and prestenotic dilation (photo courtesy of Lucia C. Fry, MD, University of Magdeburg, Germany). (Color version of figure is available at www.techgiendoscopy.com.)


Biopsy 

To allow an accurate histopathological evaluation, multiple biopsy specimens should be obtained from multiple locations. Using spiked biopsy forceps, we usually take eight biopsies per site, so enough material for flow cytometric analysis is collected. It is important not only to take biopsy specimens from ulcerative, stenotic, or tumorous tissue, but also from relatively normal-looking mucosa, since on many occasions biopsies from evident lesions contain too many cell debris or granulomatous tissue to allow for flow cytometry. In the presence of EATL, intraepithelial lymphocytes in relatively normal mucosa often show an abnormal immunophenotype identical to that of the lymphoma.29

Tattooing 

Although EATL is a condition requiring systemic treatment, surgical debulking of large tumor localizations can be indicated to prevent small bowel perforation during chemotherapy. Since debulking is only necessary for large tumors, which can usually be palpated by the surgeon without the need for an explorative enterotomy to decide on the resection margins, tattooing these lesions is often not indicated. However, if there are multiple tumors, or if strictures proximal or distal to a solitary EATL are present, tattooing of the most distal and most proximal EATL location and/or stricture allows the surgeon to choose wider resection margins which will include all relevant pathological lesions.

Additional Imaging 

VCE 

VCE is a minimally invasive method to evaluate the small bowel. Its use in complicated disease, however, is limited due to the inability to obtain biopsy specimens.30, 31 Although ulcerative jejunitis and EATL can be detected with VCE, histological confirmation is mandatory. In a study on the yield of VCE in RCD by Daum and coworkers, total small bowel examination was achieved in only 9 of 14 patients. VCE detected one case of EATL, which was confirmed using DBE.31 The risk of capsule retention due to strictures should be considered before performing VCE in patients with suspected complicated CD.

Computed Tomography Enteroclysis 

A study from Mallant and coworkers shows computed tomography enteroclysis (CTE) a useful tool in discriminating between uncomplicated CD/RCDI and RCDII/EATL.32 RCD II and EATL showed more bowel wall thickening, lymphadenopathy, and intussusception, less increase in number of small mesenteric vessels, and a smaller splenic volume compared with CD and RCD I. Additionally, the presence of hyposplenism, which is more often encountered in RCDII/EATL, can be evaluated.

Magnetic Resonance Enteroclysis 

Magnetic resonance enteroclysis (MRE) is a promising tool to evaluate the small bowel in patients with suspected RCD or EATL. Not only does MRE allow visualization of jejunal and ileal fold abnormalities, stenosis, dilation, and intraluminal masses, it also informs on bowel wall thickness, mesenterial fat infiltration, lymph node enlargement, and splenic volume. Recent research from our center shows MRE to have a sensitivity of 83% and a specificity of 94% in diagnosing RCD II or EATL.33 In our center, MRE is used as a screening tool to determine which patients should undergo DBE, and as the first modality of choice to visualize the distal small bowel that has not been reached during DBE because of non-passable strictures.

Conventional Enteroclysis 

In our opinion CTE and MRE, with their ability to evaluate not only intraluminal but also extraluminal abnormalities, have replaced conventional enteroclysis. Therefore, there is no place for conventional small bowel radiology in the diagnosis or management of CD.

Conclusions 

return to Article Outline

DBE allows endoscopical visualization of CD-related morphological abnormalities of the small bowel mucosa, identification of lesions like ulcerative jejunitis, EATL, and small bowel adenocarcinoma, obtaining biopsy specimens, and the marking of lesions for surgical resection. Furthermore, DBE has rapidly established its value in the diagnosis and management of RCD.

More research is needed to develop a structural approach in investigating patients with RCD and to determine the optimal sequence of diagnostic modalities. Additionally, DBE will enable more basic research on the role of small bowel immunological responses that trigger ulcerative jejunitis and EATL.

References 

return to Article Outline

1. 1Catassi C, Fabiani E, Ratsch IM, et al. The coeliac iceberg in Italy (A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects). Acta Paediatr Suppl. 1996;412:29–35. MEDLINE

2. 2Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:S57–S67. Abstract | Full Text | Full-Text PDF (162 KB) | CrossRef

3. 3Green PH, Jabri B. Coeliac disease. Lancet. 2003;362:383–391. Abstract | Full Text | Full-Text PDF (133 KB) | CrossRef

4. 4When is a coeliac a coeliac? (Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001). Eur J Gastroenterol Hepatol. 2001;13:1123–1128. CrossRef

5. 5Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma (French Coeliac Disease Study Group). Lancet. 2000;356:203–208. Abstract | Full Text | Full-Text PDF (289 KB) | CrossRef

6. 6Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413–424. Abstract | Full Text | Full-Text PDF (122 KB) | CrossRef

7. 7Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single centre experience. Gut. 2007;56:1373–1378. CrossRef

8. 8Brousse N, Meijer JW. Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:401–412. Abstract | Full Text | Full-Text PDF (114 KB) | CrossRef

9. 9Al-toma A, Visser OJ, van Roessel HM, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood. 2007;109:2243–2249. MEDLINE | CrossRef

10. 10Al-Toma A, Goerres MS, Meijer JW, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol. 2006;4:1322–1327. Abstract | Full Text | Full-Text PDF (143 KB) | CrossRef

11. 11Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther. 2003;18:487–494. MEDLINE | CrossRef

12. 12Al-Toma A, Verbeek WH, Visser OJ, et al. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis. 2007;39:634–641. Abstract | Full Text | Full-Text PDF (1045 KB) | CrossRef

13. 13Meijer JW, Wahab PJ, Mulder CJ. Small intestinal biopsies in celiac disease: duodenal or jejunal?. Virchows Arch. 2003;442:124–128. MEDLINE

14. 14Smith JA, Mayberry JF, Ansell ID, et al. Small bowel biopsy for disaccharidase levels: evidence that endoscopic forceps biopsy can replace the Crosby capsule. Clin Chim Acta. 1989;183:317–321. MEDLINE | CrossRef

15. 15Heine GD, Hadithi M, Groenen MJ, et al. Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy. 2006;38:42–48. CrossRef

16. 16Zhong J, Ma T, Zhang C, et al. Retrospective study of the application on double-balloon enteroscopy in 378 patients with suspected small-bowel diseases. Endoscopy. 2007;39:208–215. CrossRef

17. 17Cellier C, Cuillerier E, Patey-Mariaud de Serre N, et al. Push enteroscopy in celiac sprue and refractory sprue. Gastrointest Endosc. 1999;50:613–617. Abstract | Full-Text PDF (485 KB) | CrossRef

18. 18Al-Toma A, Verbeek WH, Mulder CJ. Update on the management of refractory coeliac disease. J Gastrointest Liver Dis. 2007;16:57–63.

19. 19Bardella MT, Minoli G, Radaelli F, et al. Reevaluation of duodenal endoscopic markers in the diagnosis of celiac disease. Gastrointest Endosc. 2000;51:714–716. Abstract | Full Text | Full-Text PDF (19 KB) | CrossRef

20. 20Cammarota G, Cesaro P, Martino A, et al. High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. Aliment Pharmacol Ther. 2006;23:61–69. MEDLINE | CrossRef

21. 21Jabbari M, Wild G, Goresky CA, et al. Scalloped valvulae conniventes: an endoscopic marker of celiac sprue. Gastroenterology. 1988;95:1518–1522. Abstract

22. 22Maurino E, Capizzano H, Niveloni S, et al. Value of endoscopic markers in celiac disease. Dig Dis Sci. 1993;38:2028–2033. MEDLINE | CrossRef

23. 23Bova JG, Friedman AC, Weser E, et al. Adaptation of the ileum in nontropical sprue: reversal of the jejunoileal fold pattern. AJR Am J Roentgenol. 1985;144:299–302.

24. 24Paolantonio P, Tomei E, Rengo M, et al. Adult celiac disease: MRI findings. Abdom Imaging. 2007;32:433–440. CrossRef

25. 25Tomei E, Marini M, Messineo D, et al. Computed tomography of the small bowel in adult celiac disease: the jejunoileal fold pattern reversal. Eur Radiol. 2000;10:119–122. MEDLINE | CrossRef

26. 26Brocchi E, Corazza GR, Caletti G, et al. Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med. 1988;319:741–744. MEDLINE | CrossRef

27. 27Dickey W, Hughes D. Erosions in the second part of the duodenum in patients with villous atrophy. Gastrointest Endosc. 2004;59:116–118. Abstract | Full Text | Full-Text PDF (155 KB) | CrossRef

28. 28Hadithi M, Al-Toma A, Oudejans J, et al. The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol. 2007;102:987–996. MEDLINE | CrossRef

29. 29Meijer JW, Mulder CJ, Goerres MG, et al. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;78–84.

30. 30Daum S, Wahnschaffe U, Glasenapp R, et al. Capsule endoscopy in refractory celiac disease. Endoscopy. 2007;39:672. CrossRef

31. 31Toth E, Ohlsson B, Ljunberg O, et al. Celiac disease diagnosed using video capsule endoscopy in a patient with Crohn’s disease. Endoscopy. 2006;38:548. CrossRef

32. 32Mallant M, Hadithi M, Al-Toma AB, et al. Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J Gastroenterol. 2007;13:1696–1700. MEDLINE

33. 33Van Weyenberg SJB, Mallant MPJH, Al-Toma A, et al. Magnetic resonance enteroclysis in adult coeliac disease: findings and comparisons between subtypes with different prognosis. Gut. 2007;56:(abstr A56).

Small Bowel Unit, Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.

Corresponding Author InformationAddress reprint requests to S. J. B. Van Weyenberg, MD, Department of Gastroenterology and Hepatology, VU University Medical Centre, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.

PII: S1096-2883(07)00111-8

doi:10.1016/j.tgie.2007.12.001


View previous. 14 of 14